Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
9 min read
Chongqing Paijin Biotechnology Co Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chongqing Paijin Biotechnology Co Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach
Read →
Latest Hotspot
9 min read
Chongqing Hilan Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chongqing Hilan Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea
Read →
Latest Hotspot
9 min read
Chongqing Chenan Biopharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chongqing Chenan Biopharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou
Read →
Latest Hotspot
9 min read
China Resources Double-Crane Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for China Resources Double-Crane Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signa
Read →
Latest Hotspot
8 min read
CHIESI Farmaceutici SpA Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for CHIESI Farmaceutici SpA: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.
Read →
Latest Hotspot
9 min read
Chengdu Zenitar Biomedical Technology Co., Ltd Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Zenitar Biomedical Technology Co., Ltd: pipeline stage, evidence package, IP risk, deal precedent, financial signals and
Read →
Latest Hotspot
9 min read
Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd., Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd.,: pipeline stage, evidence package, IP risk, deal precedent, financial
Read →
Latest Hotspot
9 min read
Chengdu Shengnuo Biotechnology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Shengnuo Biotechnology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea
Read →
Latest Hotspot
8 min read
Chengdu SciMount Pharmatech Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu SciMount Pharmatech Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach
Read →
Latest Hotspot
9 min read
Chengdu Keen Biological Technology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Keen Biological Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou
Read →
Latest Hotspot
9 min read
Chengdu Di'ao Pharmaceutical Group Co. Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Chengdu Di'ao Pharmaceutical Group Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and out
Read →
Latest Hotspot
9 min read
Charité - Universitätsmedizin Berlin Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Charité - Universitätsmedizin Berlin: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach r
Read →
<
1
<<
398
399
400
401
402
>>
2260
>